Dublin, Ireland – November 28, 2024 – Zyme Biotech, a leading provider of strategic solutions for the biopharmaceutical and life sciences industries, proudly announces a groundbreaking partnership with ValGenesis EMEA B.V., a subsidiary of ValGenesis, Inc. This collaboration brings ValGenesis’ globally renowned Validation Lifecycle Management System (VLMS) to the Middle East, addressing the critical need for cutting-edge, compliant, and efficient digital validation processes in the region.

Pioneering Digital Transformation in Life Sciences

Validation is a cornerstone of quality assurance in the life sciences sector. Yet, many organizations in the Middle East continue to rely on outdated, manual processes that are time-consuming, error-prone, and inefficient. The partnership between Zyme Biotech and ValGenesis introduces a revolutionary solution: ValGenesis VLMS, a paperless, fully digital system designed to streamline validation workflows, enhance data integrity, and ensure compliance with global standards such as FDA, EMA, and ISO regulations.

“By partnering with ValGenesis, we are bringing a best-in-class solution to organizations across the Middle East,”

“This collaboration reflects our commitment to driving operational excellence, reducing compliance risks, and empowering clients with transformative technologies.”

Comprehensive Solutions to Modernize Validation

As an authorized reseller of ValGenesis’ solutions, Zyme Biotech is set to deliver a holistic suite of services that cater to diverse client needs:

• Cloud-Based VLMS: Scalable, secure, and accessible platforms for businesses of all sizes.
• On-Premises Software: Customized for organizations with specific compliance or infrastructure requirements.
• Consulting Services: Expert support for seamless implementation, training, and process adoption.
• Real-Time Analytics: Advanced insights to monitor validation progress, performance, and regulatory compliance in real time.

With these solutions, Zyme Biotech aims to support pharmaceutical, biopharmaceutical, and life sciences companies in modernizing operations to meet the region’s growing regulatory and market demands.

Key Benefits of ValGenesis VLMS

Organizations adopting the ValGenesis platform can expect significant advantages, including:

• Operational Efficiency: Digital workflows replace manual processes, saving time and resources.
• Enhanced Data Integrity: Accurate, real-time data collection for robust regulatory compliance.
• Scalability: Modular tools that grow with your organization’s needs.
• Global Compliance: Meet stringent international standards with confidence.
• Cost Savings: Streamline operations and reduce the need for manual oversight.

A Partnership Built for Success

Based in Dublin, Ireland, Zyme Biotech brings extensive expertise in helping life sciences organizations achieve operational excellence. With a deep understanding of the Middle Eastern market, Zyme Biotech is uniquely positioned to deliver ValGenesis’ innovative technologies tailored to local needs, ensuring a seamless and impactful transformation journey.

“At Zyme Biotech, we bridge global innovation with regional expertise,” said John Ward. “Together with ValGenesis, we are redefining validation processes to help our clients meet regulatory challenges and achieve sustainable growth.”

Transform Your Validation Processes Today

Ready to embrace digital transformation? Contact Zyme Biotech today to learn how ValGenesis’ cutting-edge solutions can revolutionize your organization’s validation processes, enhance compliance, and drive efficiency.

‍

About Zyme Biotech

Zyme Biotech is a premier consultancy firm specializing in the biotechnology and pharmaceutical sectors. With over a decade of experience and a network of more than 100 leading consultants, Zyme Biotech delivers strategic insights and innovative solutions tailored to the unique needs of its clients. The company is dedicated to advancing biotechnology by providing services that ensure precision, compliance, and efficiency, thereby transforming scientific visions into market-ready realities.

About ValGenesis, Inc.

ValGenesis, Inc. is a leading provider of digital validation lifecycle management systems for the life sciences industry. Founded in 2005, ValGenesis introduced the industry's first fully paperless validation lifecycle management solution, revolutionizing compliance-based validation activities. The company's platform enhances operational efficiency, data integrity, and regulatory compliance, supporting life sciences companies in delivering safe and effective products to market more rapidly.

‍